This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Ranson criteria in acute pancreatitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The initial clinical picture is not a reliable indicator of future events in mild pancreatitis. Patients with seemingly mild disease may deteriorate rapidly and die.

The Ranson criteria and other severity scoring systems, e.g. Glasgow, APACHE II, enable early diagnosis of severe acute pancreatitis. This can be defined as the presence of three or more of the following criteria within 48 hours of admission:

  • age above than 55 years
  • blood glucose above 10 mmol/L - no history of diabetes
  • white cell count above 15 x 10^9 / L
  • LDH above 600 IU/L
  • aspartate transaminase above 200 u/L
  • corrected calcium less than 2.0 mmol/L
  • blood urea above 16 mmol/L - no improvement with intravenous fluids
  • decreasing haematocrit
  • arterial pO2 less than 8 kPa (60 mm Hg)
  • metabolic acidosis
  • serum albumin less than 32 g/L

N.B. the serum amylase value is not one of the criteria.

The mortality per postive criterion:

  • NUMBER OF POSITIVE CRITERIA
    • 0-2 <5% mortality
    • 3-4 20% mortality
    • 5-6 40% mortality
    • 7-8 100% mortality

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.